NCT00844532View on ClinicalTrials.gov

Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.

PHASE3CompletedINTERVENTIONAL

Enrollment

151

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2014

Conditions

Peripheral Vascular Disease

Interventions

DEVICE

Absolute Pro™ Peripheral Self-Expanding Stent System

Absolute Pro™ Peripheral Self-Expanding Stent System: Devices include both Absolute Pro™ and Absolute Pro™ LL Peripheral Self-Expanding Stent Systems. It is indicated for the treatment of a maximum of two bilateral de novo or restenotic atherosclerotic lesions in the native common iliac artery and/or native external iliac artery (one lesion per side).

Trial Locations (1)

95054

Abbott Vascular, Santa Clara